Effects of omega-3 fatty acids on cognitive performance: a meta-analysis G Mazereeuw, KL Lanctot, SA Chau, W Swardfager, N Herrmann Neurobiology of aging 33 (7), 1482. e17-1482. e29, 2012 | 323 | 2012 |
Zinc in depression: a meta-analysis W Swardfager, N Herrmann, G Mazereeuw, K Goldberger, T Harimoto, ... Biological psychiatry 74 (12), 872-878, 2013 | 303 | 2013 |
Potential roles of zinc in the pathophysiology and treatment of major depressive disorder W Swardfager, N Herrmann, RS McIntyre, G Mazereeuw, K Goldberger, ... Neuroscience & biobehavioral reviews 37 (5), 911-929, 2013 | 154 | 2013 |
Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis W Swardfager, N Herrmann, S Cornish, G Mazereeuw, S Marzolini, ... American heart journal 163 (4), 666-676. e3, 2012 | 140 | 2012 |
A meta-analysis of lipid peroxidation markers in major depression G Mazereeuw, N Herrmann, AC Andreazza, MM Khan, KL Lanctôt Neuropsychiatric disease and treatment, 2479-2491, 2015 | 94 | 2015 |
Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: a meta-analysis of randomized controlled trials O Jordana, KL Lanctôt, G Mazereeuw, N Herrmann The Journal of Clinical Psychiatry 76 (11), 2613, 2015 | 81 | 2015 |
Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegeneration G Mazereeuw, N Herrmann, SAL Bennett, W Swardfager, H Xu, ... Neuroscience & Biobehavioral Reviews 37 (8), 1611-1621, 2013 | 62 | 2013 |
Omega-3 fatty acids, depressive symptoms, and cognitive performance in patients with coronary artery disease: analyses from a randomized, double-blind, placebo-controlled trial G Mazereeuw, N Herrmann, PI Oh, DWL Ma, CT Wang, A Kiss, KL Lanctôt Journal of clinical psychopharmacology 36 (5), 436-444, 2016 | 52 | 2016 |
Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patients G Mazereeuw, N Herrmann, AC Andreazza, G Scola, DWL Ma, PI Oh, ... Brain, Behavior, and Immunity 60, 136-141, 2017 | 43 | 2017 |
Depression in chronic pain: might opioids be responsible? G Mazereeuw, MD Sullivan, DN Juurlink Pain 159 (11), 2142-2145, 2018 | 40 | 2018 |
Availability of naloxone in Canadian pharmacies: a population-based survey AM Cressman, G Mazereeuw, Q Guan, W Jia, T Gomes, DN Juurlink Canadian Medical Association Open Access Journal 5 (4), E779-E784, 2017 | 32 | 2017 |
Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study G Mazereeuw, N Herrmann, H Xu, AP Blanchard, D Figeys, PI Oh, ... Neuropsychiatric Disease and Treatment, 2309-2314, 2015 | 29 | 2015 |
Association between endothelial function and cognitive performance in patients with coronary artery disease during cardiac rehabilitation M Saleem, N Herrmann, A Dinoff, G Mazereeuw, PI Oh, BI Goldstein, ... Psychosomatic Medicine 81 (2), 184-191, 2019 | 24 | 2019 |
Novel phospholipid signature of depressive symptoms in patients with coronary artery disease P Chan, I Suridjan, D Mohammad, N Herrmann, G Mazereeuw, LM Hillyer, ... Journal of the American Heart Association 7 (10), e008278, 2018 | 14 | 2018 |
Baseline Oxidative Stress Is Associated with Memory Changes in Omega‐3 Fatty Acid Treated Coronary Artery Disease Patients G Mazereeuw, N Herrmann, AC Andreazza, G Scola, DWL Ma, PI Oh, ... Cardiovascular Psychiatry and Neurology 2017 (1), 3674371, 2017 | 14 | 2017 |
Omega-3/omega-6 fatty acid ratios in different phospholipid classes and depressive symptoms in coronary artery disease patients G Mazereeuw, N Herrmann, DWL Ma, LM Hillyer, PI Oh, KL Lanctôt Brain, Behavior, and Immunity 53, 54-58, 2016 | 14 | 2016 |
Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating study G Mazereeuw, N Herrmann, H Xu, D Figeys, PI Oh, S AL Bennett, ... Journal of neuroinflammation 11, 1-8, 2014 | 10 | 2014 |
Reply to: serum zinc and the risk of depression in men: observations from a 20-year follow-up study W Swardfager, N Herrmann, G Mazereeuw, KL Lanctôt Biological Psychiatry 77 (3), e13-e14, 2015 | 8 | 2015 |
Oxycodone, Hydromorphone, and the Risk of Suicide: A Retrospective Population-Based Case–Control Study G Mazereeuw, T Gomes, EM Macdonald, S Greaves, P Li, MM Mamdani, ... Drug safety 43 (8), 737-743, 2020 | 5 | 2020 |
Omega-3 Fatty Acids and Depressive Symptoms in Coronary Artery Disease G Mazereeuw University of Toronto (Canada), 2015 | 1 | 2015 |